Mobia Medical (MOBI) Reports Promising Two-Year Results from VNS-REHAB Study
Related Stocks: MOBI
Read the full articleYou might also wanna read
BHVN Stock Builds Momentum Ahead Of Multiple H2 2026 Clinical Data Readouts
The company is expected to announce clinical data for hard-to-treat epilepsy and obesity later this year.
Merit Medical Systems Inc (NASDAQ:MMSI): A Quality Investing Analysis
Quality investing analysis of Merit Medical Systems (MMSI): strong profitability, 15.1% ROIC, 29% EBIT growth, healthy balance sheet, and re
India’s lifesciences sector sees momentum build in innovation: BCG -HealthKois report
Private equity and venture capital investment in pharma rose 2.1x in five years to $ 731 million for the year ended March 2026, and biotech
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
VANCOUVER, British Columbia, July 16, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio o
Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
Under the terms of the agreement, Spero will receive exclusive global rights, excluding Greater China, to develop, research, manufacture, an
Autoimmune Disease Therapies Market Booms as AbbVie's Skyrizi Poised to Become Second-Best Selling Drug
In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion
forbes.com·8d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.